About TechLife Capital
TechLife Capital is a private equity firm founded in 2018. It is primarily based in Paris, France.
Overall TechLife Capital portfolio has seen 1 acquisition, namely Atempo. A lot of funds co-invest with TechLife Capital, with names like Elaia sharing a substantial percentage of its portfolio.
TechLife Capital has a team of 18 people, including 6 partners.
Key Metrics
TechLife Capital's Portfolio
They have invested in a total of 12 companies. Their most recent investment was in Quinten (Series B round) on Sep 20, 2022. Here is the most recent investment by TechLife Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Sep 20, 2022 | Series B | 1397 | ||
Apr 25, 2022 | Series B | 4546 | - | |
Jul 2021 | Series A | 5767 |
Here is the portfolio snapshot of TechLife Capital:
Investments by Year
The maximum number of investments were made in 2022
Team profile of TechLife Capital
TechLife Capital has a team of 18 members including 6 Partners and 1 Principal located in France. TechLife Capital's team does not sit on the board of any company as of now.Here is a list of top team members in TechLife Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Paris | - | ||
Partner | Paris | - | ||
Partner | Paris | - | ||
Partner | Paris | - | ||
Partner | Paris | - | ||
Partner | France | - | - | |
Principal | Paris | - | ||
Advisor | Paris | - | ||
Advisor | Lyon | - | ||
Advisor | Paris | - | ||
Advisor | Paris | - |
Co-investors of TechLife Capital
Over the past 8 years, 2 investors have co-invested in TechLife Capital's portfolio companies.
- Top Co-investors of TechLife Capital: 2 investors entered a company along with TechLife Capital. These include investors like Elaia (1 company).
TechLife Capital News
•
Mitem Pharma Acquires Worldwide Rights to Desferal® (Deferoxamine) With the Backing of Techlife Capital and MacsfBusiness Wire•Sep 25, 2024•MITEM Pharma, TechLife Capital
•
Counsel to TechLife Capital for the acquisition of EvolutisMoncey•Jul 27, 2023•Evolutis, TechLife Capital, Adaxtra Capital
•
Quinten raises 14 million euros to deploy its health data exploitation softwareusine-digitale.fr•Sep 20, 2022•Quinten, MACSF, TechLife Capital, Quinten Health
•
•
Flash Therapeutics Scales up, Becoming a Leader in the Bioproduction of DNA and RNA Lentiviral TechnologiesBusiness Wire•Sep 07, 2021•Flash Therapeutics, Elaia, TechLife Capital
